Solutions Through Immunology

Advancing Vaccines and BioTherapeutics

Our GMP, Your IND

Advancing Vaccines and BioTherapeutics

Breakthroughs Delivered

Advancing Vaccines and BioTherapeutics

About ABL

ABL provides contract manufacturing and laboratory research services to advance leading vaccines and therapies from clinical development to the commercial market.

Learn More
Spotlight

ABL Awarded NIH Contract for HIV Vaccine Development Worth Up to $318 Million

ABL announced today it has been awarded the recompetition of the contract for “Preclinical Development Support” by the Division of AIDS (DAIDS) within the National Institute of Allergy and Infectious Disease (NIAID) of the National Institutes of Health (NIH). The contract will run for a total of seven years with a maximum funding level of $318 million.

Read More

ABL Increases Aseptic Fill/Finish Capacity with State-of-the-Art, Fully Automated Vial Filling Line

ABL is proud to announce the successful expansion of its aseptic fill/finish operations at its Rockville, MD GMP biomanufacturing facility with the installation of a new, fully automated vial filling system.

Read More

ABL, Inc. Earned GCLP Certificate of Accreditation

In Q1 2017, ABL was awarded a certificate of full accreditation after satisfactorily implementing the requirements set out in the Good Clinical Laboratory Practice (GCLP), an international standard developed by the World Health Organization (WHO) to close the gap between preclinical GLP and GCP testing.

Learn More

The Division of AIDS Awards ABL a Seven-Year Contract to Provide HIV Microbicide Research and Product Development Support

ABL is pleased to announce the award of a contract for the “Comprehensive Resources for HIV Microbicides and Biomedical Prevention.” ABL will provide the Division of AIDS in the National Institute of Allergy and Infectious Disease with a comprehensive suite of preclinical product development services for candidate non-vaccine biomedical prevention products to prevent sexual HIV transmission.

Read More